PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.1 AUD
5.26%
Market Closed
Updated:
May 15, 2024
PYC Therapeutics Ltd
Depreciation & Amortization
|
PYC Therapeutics Ltd
Depreciation & Amortization Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Depreciation & Amortization
-AU$429.9k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-6%
|
|
|
Immutep Ltd
ASX:IMM
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mesoblast Ltd
ASX:MSB
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Depreciation & Amortization
-AU$988.8k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Depreciation & Amortization?
Depreciation & Amortization
-429.9k
AUD
-429.9k
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Depreciation & Amortization amounts to -429.9k AUD.
What is PYC Therapeutics Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-6%
-6%
Over the last year, the Depreciation & Amortization growth was 51%. The average annual Depreciation & Amortization growth rates for PYC Therapeutics Ltd have been -14% over the past three years , -40% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
